Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

S130

Copy Product Info
😃Good
Catalog No. T12819Cas No. 1160852-22-1

S130 is a high affinity, selectiveATG4B (a major cysteine protease) inhibitor (IC50 of 3.24 μM).It suppresses autophagy flux.

S130

S130

Copy Product Info
😃Good
Catalog No. T12819Cas No. 1160852-22-1
S130 is a high affinity, selectiveATG4B (a major cysteine protease) inhibitor (IC50 of 3.24 μM).It suppresses autophagy flux.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$2976-8 weeks6-8 weeks
25 mg$9876-8 weeks6-8 weeks
50 mg$1,3606-8 weeks6-8 weeks
100 mg$1,8606-8 weeks6-8 weeks
1 mL x 10 mM (in DMSO)$3186-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
S130 is a high affinity, selectiveATG4B (a major cysteine protease) inhibitor (IC50 of 3.24 μM).It suppresses autophagy flux.
Targets&IC50
ATG4B:3.24 µM
In vitro
S130 suppresses autophagy and activates apoptosis by inhibiting ATG4B, leading to enhanced cytotoxicity. S130 (0-25 μM; 48 hours) induces cell death through ATG4B inhibition at doses higher than 6.3 μM, without causing necroptosis. Nutrient deprivation enhances S130-induced cytotoxicity. S130 (0-10 μM; 24 hours) suppresses approximately 79% of full-length LC3-GST cleavage at 10 μM, while no substrates were processed in ATG4B KO cells. S130 exhibits significant inhibitory effects on ATG4B.
In vivo
Tumor growth suppressed by S130 (20 mg/kg; i.p.; daily; 3 weeks), S130 shows an efficient in vivo antitumor effect with a sound safety on vital organs.
Chemical Properties
Molecular Weight387.47
FormulaC24H25N3O2
Cas No.1160852-22-1
SmilesCCN(CC)CCCNC(=O)c1cnc2C(=O)c3ccccc3-c3cccc1c23
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 125 mg/mL (322.61 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (8.52 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5808 mL12.9042 mL25.8084 mL129.0422 mL
5 mM0.5162 mL2.5808 mL5.1617 mL25.8084 mL
10 mM0.2581 mL1.2904 mL2.5808 mL12.9042 mL
20 mM0.1290 mL0.6452 mL1.2904 mL6.4521 mL
50 mM0.0516 mL0.2581 mL0.5162 mL2.5808 mL
100 mM0.0258 mL0.1290 mL0.2581 mL1.2904 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy S130 | purchase S130 | S130 cost | order S130 | S130 chemical structure | S130 in vivo | S130 in vitro | S130 formula | S130 molecular weight